72M non-smoker with progressive exertional dyspnea and dry cough over 18 months. HRCT shows bilateral basal-predominant honeycombing with traction bronchiectasis β typical UIP pattern. PFTs show FVC 62%, DLCO 48%. ANA and anti-CCP negative. Rheumatologist found no connective tissue disease. Per ATS/ERS 2022 IPF guidelines, does this patient still need surgical lung biopsy for diagnosis, or is the HRCT pattern sufficient? When is BAL/cryobiopsy preferred?
Per ATS/ERS/JRS/ALAT 2022 IPF Diagnostic Guidelines β this is well answered: **Is surgical lung biopsy (SLB) needed for typical UIP on HRCT?** NO β a typical UIP pattern on HRCT in the correct clinical context is sufficient for diagnosis without biopsy. ATS/ERS 2022 guidelines state that typical UIP pattern (bilateral, basal, subpleural honeycombing Β± peripheral traction bronchiectasis) in a patient >60 years, non-smoker/ex-smoker, with progressive dyspnea and no identifiable cause β is diagnostic of IPF without further tissue sampling. **HRCT UIP Pattern Classification:** 1. **Typical UIP:** Honeycombing Β± traction bronchiectasis (basal, subpleural) β IPF diagnosis without biopsy 2. **Probable UIP:** Traction bronchiectasis without honeycombing β BAL/cryobiopsy recommended 3. **Indeterminate:** Features inconsistent with UIP β MDT discussion + consider biopsy 4. **Alternative diagnosis:** Pattern suggests another ILD β pursue alternative diagnosis **When is BAL / Cryobiopsy preferred?** - HRCT shows probable or indeterminate UIP pattern (no honeycombing) - Patient age <50 with atypical features - To rule out alternative diagnosis (HP, NSIP, DIP) - Transbronchial cryobiopsy (TBLC) is now preferred over SLB (ATS 2022): lower morbidity, 70-80% diagnostic yield, can be done under moderate sedation. - SLB reserved for TBLC failures or inconclusive results, or where cryobiopsy is unavailable. **For this patient:** Typical UIP + age 72 + no CTD + no identifiable cause = IPF diagnosis confirmed WITHOUT biopsy. Start antifibrotic therapy (nintedanib or pirfenidone) for FVC <80% with rapid decline. **MDT discussion is mandatory** for all ILD/IPF cases per ATS/ERS guidelines.
Be specific. Cite references where possible. Your credentials will be shown with your answer.